Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex N Bullock

Showing results (31-40 of 115) with videos related to

Pageof 12
Sort By:
Biomedicines|March 6, 2021
Challenges and Opportunities for Drug Repositioning in Fibrodysplasia Ossificans ProgressivaFrancesc Ventura, Eleanor Williams, Makoto Ikeya, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2007
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinasesOleg Fedorov, Brian Marsden, Vanda Pogacic, et al.
The Biochemical Journal|January 7, 2017
Structure and inhibitor specificity of the PCTAIRE-family kinase CDK16Sarah E Dixon-Clarke, Saifeldin N Shehata, Tobias Krojer, et al.
Cancer Research|July 20, 2007
Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activityVanda Pogacic, Alex N Bullock, Oleg Fedorov, et al.
The Journal of Biological Chemistry|November 5, 2014
Small molecules dorsomorphin and LDN-193189 inhibit myostatin/GDF8 signaling and promote functional myoblast differentiationDaniel Horbelt, Jan H Boergermann, Apirat Chaikuad, et al.
Journal of Molecular Biology|June 29, 2013
Molecular architecture of the ankyrin SOCS box family of Cul5-dependent E3 ubiquitin ligasesJoão R C Muniz, Kunde Guo, Nadia J Kershaw, et al.
The Biochemical Journal|October 1, 2017
Structural complexity in the KCTD family of Cullin3-dependent E3 ubiquitin ligasesDaniel M Pinkas, Caroline E Sanvitale, Joshua C Bufton, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2018
Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitorsChalada Suebsuwong, Daniel M Pinkas, Soumya S Ray, et al.
Bone|March 20, 2018
Effects of FKBP12 and type II BMP receptors on signal transduction by ALK2 activating mutations associated with genetic disordersAiko Machiya, Sho Tsukamoto, Satoshi Ohte, et al.
The EMBO Journal|June 21, 2008
The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylationSonja Baumli, Graziano Lolli, Edward D Lowe, et al.
Pageof 12

Showing results (31-40 of 115) with videos related to

Sort By:
Pageof 12
Biomedicines|March 6, 2021
Challenges and Opportunities for Drug Repositioning in Fibrodysplasia Ossificans ProgressivaFrancesc Ventura, Eleanor Williams, Makoto Ikeya, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2007
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinasesOleg Fedorov, Brian Marsden, Vanda Pogacic, et al.
The Biochemical Journal|January 7, 2017
Structure and inhibitor specificity of the PCTAIRE-family kinase CDK16Sarah E Dixon-Clarke, Saifeldin N Shehata, Tobias Krojer, et al.
Cancer Research|July 20, 2007
Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activityVanda Pogacic, Alex N Bullock, Oleg Fedorov, et al.
The Journal of Biological Chemistry|November 5, 2014
Small molecules dorsomorphin and LDN-193189 inhibit myostatin/GDF8 signaling and promote functional myoblast differentiationDaniel Horbelt, Jan H Boergermann, Apirat Chaikuad, et al.
Journal of Molecular Biology|June 29, 2013
Molecular architecture of the ankyrin SOCS box family of Cul5-dependent E3 ubiquitin ligasesJoão R C Muniz, Kunde Guo, Nadia J Kershaw, et al.
The Biochemical Journal|October 1, 2017
Structural complexity in the KCTD family of Cullin3-dependent E3 ubiquitin ligasesDaniel M Pinkas, Caroline E Sanvitale, Joshua C Bufton, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2018
Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitorsChalada Suebsuwong, Daniel M Pinkas, Soumya S Ray, et al.
Bone|March 20, 2018
Effects of FKBP12 and type II BMP receptors on signal transduction by ALK2 activating mutations associated with genetic disordersAiko Machiya, Sho Tsukamoto, Satoshi Ohte, et al.
The EMBO Journal|June 21, 2008
The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylationSonja Baumli, Graziano Lolli, Edward D Lowe, et al.
Pageof 12